Inventor · disambiguated record
Sreekanth A. Ramachandran
Also filed as: RAMACHANDRAN SREEKANTH · RAMACHANDRAN SREEKANTH A
11 granted patents·10 pending applications·45 citations·filing 2009–2024
85Inventor score
Files withNUVATION BIO INC9MEDIVATION TECH LLC4INTEGRAL BIOSCIENCES PRIVATE LTD3ANACOR PHARMACEUTICALS INC21CBIO INC1
Top patents by PatentIndex Score
21 records- 0193US8343944B2Trisubstituted boron-containing moleculesANACOR PHARMACEUTICALS INC·Filed 2010·Granted Jan 1, 2013·34 cites·59 claims
- 0283US10793561B21,8-naphthyridinone compounds and uses thereofNUVATION BIO INC·Filed 2018·Granted Oct 6, 2020·3 cites·76 claims
- 0382US10030004B2Compounds and methods of useMEDIVATION TECH LLC·Filed 2014·Granted Jul 24, 2018·6 cites·10 claims
- 0479US11028058B2Heterocyclic compounds as adenosine antagonistsNUVATION BIO INC·Filed 2018·Granted Jun 8, 2021·2 cites·52 claims
- 0575US11053216B2Compounds and methods of useMEDIVATION TECH LLC·Filed 2019·Granted Jul 6, 2021·0 cites·19 claims
- 0673US11702401B2Compounds and methods of useMEDIVATION TECH LLC·Filed 2021·Granted Jul 18, 2023·0 cites·26 claims
- 0771US12325720B2Ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP1) inhibitors and uses thereof1CBIO INC·Filed 2024·Granted Jun 10, 2025·0 cites·11 claims
- 0862US2022298142A1Heterocyclic compounds as adenosine antagonistsNUVATION BIO INC·Filed 2022·Application pending·0 cites
- 0962US2022169648A11,8-naphthyridinone compounds and uses thereofNUVATION BIO INC·Filed 2022·Application pending·0 cites
- 1061US2022220111A11,8-naphthyridinone compounds and uses thereofNUVATION BIO OPERATING COMPANY INC·Filed 2021·Application pending·0 cites
- 1161US2010256092A1Boron-containing small moleculesANACOR PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1261US2022135598A1Ectonucleotide pyrophosphatase-phosphodiesterase-1 (enpp1) inhibitors and uses thereofINTEGRAL BIOSCIENCES PRIVATE LTD·Filed 2021·Application pending·0 cites
- 1360US11306071B2Heterocyclic compounds as adenosine antagonistsNUVATION BIO INC·Filed 2020·Granted Apr 19, 2022·0 cites·20 claims
- 1459US2021292285A1Heterocyclic compounds as adenosine antagonistsNUVATION BIO INC·Filed 2021·Application pending·0 cites
- 1557US10501436B2Compounds and methods of useMEDIVATION TECH LLC·Filed 2018·Granted Dec 10, 2019·0 cites·21 claims
- 1654US11254670B21,8-naphthyridinone compounds and uses thereofNUVATION BIO INC·Filed 2020·Granted Feb 22, 2022·0 cites·37 claims
- 1745US2023066315A1Compounds and uses thereofNUVATION BIO INC·Filed 2020·Application pending·0 cites
- 1844US2020171030A1Dual inhibitors of alk5 and p38a map kinaseINTEGRAL BIOSCIENCES PRIVATE LTD·Filed 2019·Application pending·0 cites
- 1943US2022119367A1Heterocyclic compounds as adenosine antagonistsNUVATION BIO INC·Filed 2020·Application pending·0 cites
- 2038US12428395B2Heterocyclic compounds as kinase inhibitor and uses thereofSPEROGENIX THERAPEUTICS LTD·Filed 2020·Granted Sep 30, 2025·0 cites·18 claims
- 2138US2020206233A1Heterocyclic compounds as mutant idh inhibitorsINTEGRAL BIOSCIENCES PRIVATE LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sreekanth A. Ramachandran files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →